
Mayne Pharma shares rise over US deal
Mayne Pharma shares have soared 19 per cent to a near five-month high, after the Adelaide-based pharmaceutical company inked an exclusive long-term deal to sell a new contraceptive drug in the United States.
Mayne Pharma shares have soared 19 per cent to a near five-month high, after the Adelaide-based pharmaceutical company inked an exclusive long-term deal to sell a new contraceptive drug in the United States.
Australia must accept that its drug policies have failed and pill testing must be introduced to save young lives, the nation’s former top cop says.
Get InDaily in your inbox. Daily. The best local news sent straight to your inbox every workday at lunchtime.
Thanks for signing up to the InDaily newsletter.